Sphenopalatine Ganglion Blockade in Migraine

Clinical trial NCT05210192 · UNKNOWN

Trial details

NCT number: NCT05210192
Sponsor: Afyonkarahisar Health Sciences University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Episodic Migraine

Start date: 2022-04-01
Primary completion: 2022-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.